In particular, PHB-driven Wnt/β-catenin signaling and the Snai2–NADSYN1–PHB pathway have been shown to promote migration, invasion, and adverse phenotypes in bladder cancer models. This evidence concerns the gene PHB1 and urinary bladder carcinoma.